Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines

[1] Swain SM(2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2869-2879

[2] Whaley FS(2005)Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study J Clin Oncol 23 8597-8605

[3] Ewer MS(1976)Echocardiographic evaluation of adriamycin cardiotoxicity in children Cancer Treat Rep 60 1281-1284

[4] Doyle JJ(1983)Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy J Cancer Res Clin Oncol 106 136-142

[5] Neugut AI(1984)A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin J Clin Oncol 2 112-117

[6] Jacobson JS(2013)Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 77-84

[7] Grann VR(2015)Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 16 233-270

[8] Hershman DL(2012)Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 30 2876-2884

[9] Ramos A(2002)Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy Ann Oncol 13 710-715

[10] Meyer RA(2009)Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction J Clin Oncol 27 6117-6123

[1] Swain SM(2003)Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2869-2879

[2] Whaley FS(2005)Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study J Clin Oncol 23 8597-8605

[3] Ewer MS(1976)Echocardiographic evaluation of adriamycin cardiotoxicity in children Cancer Treat Rep 60 1281-1284

[4] Doyle JJ(1983)Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy J Cancer Res Clin Oncol 106 136-142

[5] Neugut AI(1984)A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin J Clin Oncol 2 112-117

[6] Jacobson JS(2013)Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy J Am Coll Cardiol 61 77-84

[7] Grann VR(2015)Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging Eur Heart J Cardiovasc Imaging 16 233-270

[8] Hershman DL(2012)Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 30 2876-2884

[9] Ramos A(2002)Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy Ann Oncol 13 710-715

[10] Meyer RA(2009)Dose-dense adjuvant doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction J Clin Oncol 27 6117-6123